GleamWall
中文EN

HTFL Heartflow, Inc.

Surgical & Medical Instruments & Apparatus · Nasdaq · SEC CIK 1464521 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY47.4%
TTM net income YoY37.0%
TTM EPS YoY106.6%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin81.8%
Operating margin-33.1%
Net margin-33.1%
FCF margin-23.5%
EBITDA margin-30.8%

Returns

ROE-29.4%
ROA-22.0%
ROIC (approx.)-58.2%
Asset turnover0.66x

Leverage & solvency

Liabilities / assets20.5%
Debt / equity0.00x
Current ratio4.41x
Interest coverage-4,937.50x

Cash quality & payout

Operating cash flow / net income0.62x
Accruals ratio-8.4%
Payout ratio—
Capex / revenue3.0%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31
Income statement
Revenue$176.03M$125.81M$87.17M
Cost of revenue$40.84M$31.36M$29.12M
Gross profit$135.20M$94.45M$58.05M
R&D expense$64.92M$43.52M$35.85M
SG&A expense$134.34M$112.15M$95.11M
Operating income-$64.07M-$61.22M-$72.91M
Interest expense$15.17M$22.77M$24.69M
Pretax income-$116.87M-$96.37M-$95.11M
Income tax-$76,000$53,000$547,000
Net income-$116.79M-$96.43M-$95.66M
EBITDA-$58.63M-$55.86M-$68.17M
EPS (basic)-3.17-17.98-25.32
EPS (diluted)-3.17-17.98-25.32
Weighted avg. shares (diluted)36.85M5.36M4.89M
Balance sheet
Cash & equivalents$44.78M$55.84M$122.77M
Short-term investments$132.01M——
Receivables$29.34M$24.64M—
Current assets$220.20M$82.29M—
PP&E, net$8.59M$8.92M—
Total assets$359.45M$118.70M—
Current liabilities$42.37M$33.60M—
Total liabilities$58.80M$209.62M—
Shareholders' equity$300.65M-$859.48M-$777.56M
Shares outstanding85.28M6.12M—
Cash flow statement
Operating cash flow-$54.02M-$69.00M-$76.43M
Capital expenditure$5.03M$4.36M$6.11M
Free cash flow-$59.05M-$73.36M-$82.54M
Investing cash flow-$238.57M-$4.36M-$6.11M
Financing cash flow$286.04M$2.24M$169.32M
Depreciation & amortization$5.44M$5.36M$4.74M
Stock-based compensation$13.96M$10.21M$11.87M
Share buybacks——$228,000

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.